Vandetanib in locally advanced or metastatic differentiated thyroid cancer refractory to radioiodine therapy.

Saved in:
Bibliographic Details
Title: Vandetanib in locally advanced or metastatic differentiated thyroid cancer refractory to radioiodine therapy.
Authors: Brose, Marcia S.1 marcia.brose@jefferson.edu, Capdevila, Jaume2, Elisei, Rossella3, Bastholt, Lars4, Führer-Sakel, Dagmar5, Leboulleux, Sophie6,7, Iwao Sugitani8, Taylor, Matthew H.9, Zhuoying Wang10,11, Wirth, Lori J.12, Worden, Francis P.13, Bernard, John14, Caferra, Paolo15,16, Colzani, Raffaella M.14, Shiguang Liu14, Schlumberger, Martin6
Source: Endocrine-Related Cancer. Aug2024, Vol. 31 Issue 8, p12-24. 13p.
Database: Academic Search Ultimate
Description
ISSN:13510088
DOI:10.1530/ERC-23-0354